Publications
Temsirolimus (T) in patients (pts) with solid tumors with mTOR mutation: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Srkalovic, G,
Rothe, M,
Mangat, PK,
Garrett-Mayer, E,
Nazemzadeh, R,
Cannon, TL,
Duvivier, HL,
Yost, KJ,
Pakkala, S,
Alva, AS,
Behl, D,
Gold, PJ,
Calfa, CJ,
Ngirailemesang, M,
Powell, SF,
O'Lone, R,
Grantham, GN,
Halabi, S,
Schilsky, RL,
Journal of Clinical Oncology, 2022 Jun; DOI:10.1200/jco.2022.40.16_suppl.3114 BRCAAWAY: A randomized phase 2 trial of abiraterone, olaparib, or abiraterone + olaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) with DNA repair defects.
Hussain, MHA,
Kocherginsky, M,
Agarwal, N,
Zhang, J,
Adra, N,
Paller, CJ,
Picus, J,
Reichert, ZR,
Szmulewitz, RZ,
Tagawa, ST,
Whang, YE,
Dreicer, R,
Kuzel, T,
Bazzi, L,
Gerke, TA,
Daignault-Newton, S,
Chinnaiyan, A,
Antonarakis, ES,
Journal of Clinical Oncology, 2022 Jun; DOI:10.1200/jco.2022.40.16_suppl.5018 Long-term survival in advanced melanoma for patients treated with nivolumab plus ipilimumab in CheckMate 067.
Hodi, FS,
Chiarion -Sileni, V,
Lewis, KD,
Grob, J-J,
Rutkowski, P,
Lao, CD,
Cowey, CL,
Schadendorf, D,
Wagstaff, J,
Dummer, R,
Queirolo, P,
Smylie, M,
Butler, MO,
Hill, AG,
Marquez-Rodas, I,
Haanen, JBAG,
Durani, P,
Wang, P,
Wolchok, JD,
Larkin, J,
Journal of Clinical Oncology, 2022 Jun; DOI:10.1200/jco.2022.40.16_suppl.9522 Dynamic susceptibility contrast-MRI parameters, ADC values, and the T2-FLAIR mismatch sign are useful to differentiate between H3-mutant and H3-wild-type high-grade midline glioma
Kurokawa, R,
Kurokawa, M,
Baba, A,
Ota, Y,
Kim, J,
Capizzano, A,
Srinivasan, A,
Moritani, T,
Eur Radiol, 2022 Jun; DOI:10.1007/s00330-021-08476-7 GATA3 expression in pulmonary mucinous adenocarcinoma presenting as a distant metastasis: A case report
Shaker, N,
Hanline, CC,
Tynski, IM,
Tynski, Z,
Amadi, CC,
Parwani, A,
Shilo, K,
Human Pathology Reports, 2022 Jun; DOI:10.1016/j.hpr.2022.300642 Risk of obstructive sleep apnea after treatment of head and neck squamous cell carcinoma: a cross-sectional study
Gavidia, R,
Dunietz, GL,
O'Brien, LM,
Schütz, SG,
Spector, ME,
Swiecicki, PL,
Chervin, RD,
J Clin Sleep Med, 2022 Jun; DOI:10.5664/jcsm.9954 Cost-Effectiveness of Outreach Strategies for Stool-Based Colorectal Cancer Screening in a Medicaid Population
Karlitz, JJ,
Fendrick, AM,
Bhatt, J,
Coronado, GD,
Jeyakumar, S,
Smith, NJ,
Plescia, M,
Brooks, D,
Limburg, P,
Lieberman, D,
Popul Health Manag, 2022 Jun; DOI:10.1089/pop.2021.0185 A pilot induction regimen incorporating dinutuximab and sargramostim for the treatment of newly diagnosed high-risk neuroblastoma: A report from the Children's Oncology Group.
Federico, SM,
Naranjo, A,
Zhang, F,
Marachelian, A,
Desai, AV,
Shimada, H,
Braunstein, SE,
Tinkle, CL,
Yanik, GA,
Asgharzadeh, S,
Sondel, PM,
Yu, AL,
Acord, M,
Parisi, MT,
Shulkin, BL,
DuBois, SG,
Bagatell, R,
Park, JR,
Furman, WL,
Shusterman, S,
Journal of Clinical Oncology, 2022 Jun; DOI:10.1200/jco.2022.40.16_suppl.10003 Cost-effectiveness of mt-sDNA versus mailed FIT outreach for Medicare Advantage enrollees using the CRC-AIM microsimulation model.
Bhatt, J,
Chen, JV,
Vahdat, V,
Fendrick, A,
Lieberman, DA,
Brooks, D,
Ozbay, AB,
Karlitz, JJ,
Journal of Clinical Oncology, 2022 Jun; DOI:10.1200/jco.2022.40.16_suppl.e18827 Comparison of simulated outcomes between stool- and blood-based colorectal cancer screening tests.
Fendrick, A,
Vahdat, V,
Chen, JV,
Lieberman, DA,
Karlitz, JJ,
Limburg, PJ,
Ozbay, AB,
Kisiel, JB,
Journal of Clinical Oncology, 2022 Jun; DOI:10.1200/jco.2022.40.16_suppl.10529 Outcomes with novel combinations in nonclear cell renal cell carcinoma (nccRCC): ORACLE study.
Kilari, D,
Szabo, A,
Ghatalia, P,
Rose, TL,
Dong, H,
Weise, N,
Zhuang, TZ,
Alloghbi, A,
Jain, RK,
Alva, AS,
Tripathi, A,
Basu, A,
Davis, NB,
Brundage, J,
Emamekhoo, H,
Zakharia, Y,
Koshkin, VS,
Bilen, MA,
Heath, EI,
McKay, RR,
Journal of Clinical Oncology, 2022 Jun; DOI:10.1200/jco.2022.40.16_suppl.4545 Urinary MyProstateScore (MPS) to rule out clinically-significant cancer in men with equivocal (PI-RADS 3) multiparametric MRI: addressing an unmet clinical need
Tosoian, JJ,
Singhal, U,
Davenport, MS,
Wei, JT,
Montgomery, JS,
George, AK,
Salami, SS,
Mukundi, SG,
Siddiqui, J,
Kunju, LP,
Tooke, BP,
Ryder, CY,
Dugan, SP,
Chopra, Z,
Botbyl, R,
Feng, Y,
Sessine, MS,
Eyrich, NW,
Ross, AE,
Trock, BJ,
Tomlins, SA,
Palapattu, GS,
Chinnaiyan, AM,
Niknafs, YS,
Morgan, TM,
Urology, 2022 Jun; DOI:10.1016/j.urology.2021.11.033 Cellular engagement and interaction in the tumor microenvironment predict non-response to PD-1/PD-L1 inhibitors in metastatic non-small cell lung cancer.
Qin, A,
Lima, F,
Bell, S,
Kalemkerian, GP,
Schneider, BJ,
Ramnath, N,
Lew, M,
Krishnan, S,
Mohammed, S,
Rao, A,
Frankel, TL,
Sci Rep, 2022 May; DOI:10.1038/s41598-022-13236-8 Accuracy of Central Neuro-Imaging Review of DIPG Compared with Histopathology in the International DIPG Registry
Lazow, MA,
Fuller, C,
DeWire, M,
Lane, A,
Bandopadhayay, P,
Bartels, U,
Bouffet, E,
Cheng, S,
Cohen, KJ,
Cooney, TM,
Coven, SL,
Dholaria, H,
Diez, B,
Dorris, K,
El-Ayadi, M,
El-Sheikh, A,
Fisher, PG,
Fonseca, A,
Garcia Lombardi, M,
Greiner, RJ,
Goldman, S,
Gottardo, N,
Gururangan, S,
Hansford, JR,
Hassall, T,
Hawkins, C,
Kilburn, L,
Koschmann, C,
Leary, SE,
Ma, J,
Minturn, JE,
Monje-Deisseroth, M,
Packer, R,
Samson, Y,
Sandler, ES,
Sevlever, G,
Tinkle, CL,
Tsui, K,
Wagner, LM,
Zaghloul, M,
Ziegler, DS,
Chaney, B,
Black, K,
Asher, A,
Drissi, R,
Fouladi, M,
Jones, BV,
Leach, JL,
Neuro Oncol, 2022 May; DOI:10.1093/neuonc/noab245 Patient and Provider Perspectives on Enrollment in Precision Oncology Research: Qualitative Ethical Analysis
Spector-Bagdady, K,
Kent, M,
Krenz, CD,
Brummel, C,
Swiecicki, PL,
Brenner, JC,
Shuman, AG,
JMIR Cancer, 2022 May; DOI:10.2196/35033 Better Understanding the Timing of Androgen Deprivation Therapy (TOAD) Trial Outcomes: Impacts of Prior ADT
Stensland, KD,
Devasia, T,
Caram, MEV,
Chapman, C,
Zaslavsky, A,
Morgan, TM,
Hollenbeck, BK,
Sparks, JB,
Burns, J,
Vedapudi, V,
Duchesne, GM,
Tsodikov, A,
Skolarus, TA,
JNCI Cancer Spectr, 2022 May; DOI:10.1093/jncics/pkac025 Survival Outcomes Associated With Cytoreductive Nephrectomy in Patients With Metastatic Clear Cell Renal Cell Carcinoma.
Chakiryan, NH,
Gore, LR,
Reich, RR,
Dunn, RL,
Jiang, DD,
Gillis, KA,
Green, E,
Hajiran, A,
Hugar, L,
Zemp, L,
Zhang, J,
Jain, RK,
Chahoud, J,
Spiess, PE,
Manley, BJ,
Sexton, WJ,
Hollenbeck, BK,
Gilbert, SM,
JAMA Netw Open, 2022 May; DOI:10.1001/jamanetworkopen.2022.12347 Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection
Cani, AK,
Dolce, EM,
Darga, EP,
Hu, K,
Liu, C-J,
Pierce, J,
Bradbury, K,
Kilgour, E,
Aung, K,
Schiavon, G,
Carroll, D,
Carr, TH,
Klinowska, T,
Lindemann, J,
Marshall, G,
Rowlands, V,
Harrington, EA,
Barrett, JC,
Sathiyayogan, N,
Morrow, C,
Sero, V,
Armstrong, AC,
Baird, R,
Hamilton, E,
Im, S-A,
Jhaveri, K,
Patel, MR,
Dive, C,
Tomlins, SA,
Udager, AM,
Hayes, DF,
Paoletti, C,
Mol Oncol, 2022 May; DOI:10.1002/1878-0261.13150 Risk factors associated with metastatic site failure in patients with high-risk neuroblastoma
Lucas, JT,
Wakefield, DV,
Doubrovin, M,
Li, Y,
Santiago, T,
Federico, SM,
Merchant, TE,
Davidoff, AM,
Krasin, MJ,
Shulkin, BL,
Santana, VM,
Lee Furman, W,
Clin Transl Radiat Oncol, 2022 May; DOI:10.1016/j.ctro.2022.02.009 Higher Long-term Quality of Life Metrics After Video-Assisted Thoracoscopic Surgery Lobectomy Compared With Robotic-Assisted Lobectomy
Williams, AM,
Zhao, L,
Grenda, TR,
Kathawate, RG,
Biesterveld, BE,
Bhatti, UF,
Carrott, PW,
Lagisetty, KH,
Chang, AC,
Lynch, W,
Lin, J,
Reddy, RM,
Ann Thorac Surg, 2022 May; DOI:10.1016/j.athoracsur.2020.05.033 Risk of HBV reactivation during therapies for HCC: A systematic review
Papatheodoridi, M,
Tampaki, M,
Lok, AS,
Papatheodoridis, GV,
Hepatology, 2022 May; DOI:10.1002/hep.32241 <sup>11</sup>C-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence
Bag, AK,
Wing, MN,
Sabin, ND,
Hwang, SN,
Armstrong, GT,
Han, Y,
Li, Y,
Snyder, SE,
Robinson, GW,
Qaddoumi, I,
Broniscer, A,
Lucas, JT,
Shulkin, BL,
J Nucl Med, 2022 May; DOI:10.2967/jnumed.120.261891 Combined analysis of T cell activation and T cell-mediated cytotoxicity by imaging cytometry
Chanda, MK,
Shudde, CE,
Piper, TL,
Zheng, Y,
Courtney, AH,
The Journal of Immunology, 2022 May; DOI:10.4049/jimmunol.208.supp.172.07 Enhanced cytotoxic CD8+ T cell (CTL) antigen recognition by LCK activation
Zheng, Y,
Piper, TL,
Courtney, AH,
The Journal of Immunology, 2022 May; DOI:10.4049/jimmunol.208.supp.55.14 Neurofibromatosis type 2 versus sporadic vestibular schwannoma: The utility of MR diffusion and dynamic contrast-enhanced imaging
Ota, Y,
Liao, E,
Capizzano, AA,
Baba, A,
Kurokawa, R,
Kurokawa, M,
Srinivasan, A,
J Neuroimaging, 2022 May; DOI:10.1111/jon.12966 